DIOPTEX

GLOBAL LEADER IN CORNEAL TECHNOLOGY

INNOVATION IS OUR BUSINESS

 

 

COMPANY

MISSION

DIOPTEX is dedicated to research and development on the highest level in the field of keratoconus treatment in order to be able to provide outstanding solutions for patients eyesight. We offer solutions that no other technology can provide.

The result of our activities are most innovative technologies and medical products for the surgical treatment of keratoconus and other eye disorders.

 

 

COMPANY

DATA

DIOPTEX Forschungs-, Entwicklungs- und Vertriebs GmbH (DIOPTEX GmbH) was founded by Dr. Albert Daxer, an internationally leading ophthalmic surgeon specialized in corneal and refractive surgery and keratoconus. The company focuses on ophthalmic research and the development of new and innovative technologies for eye surgery. A special focus is on the treatment of keratoconus and severe cases of myopia - diseases which often end in corneal transplantation and legal blindnes. The new DIOPTEX technologies for keratoconus treatment such as the PocketMaker, MyoRing and KERALUX Crosslinking are real milestones in the field and the beginning of a new era of keratoconus treatment. For the first time in the history of keratoconus treatments, these products allow for something like a "cure" of the disease. There are no other technologies which are as safe and effective. In light of these innovations, all other available treatment options can be considered as obsolet and inadequate. All products are protected by international patents.